Cleveland Jewish News: William Schiemann, associate professor of general medical sciences, led a team of researchers who found a link between a micro ribonucleic acid molecule and late-stage breast cancer. “Our micro RNA inactivates [a protein called] Bim, and we think this leads to chemo resistance to these metastatic cancers,” Schiemann said. Lower Bim levels, coupled with higher miR-181a levels, allow the spread of cancer.
Medicine’s William Schiemann and researchers target molecule’s role in late-stage breast cancer
- Researchers led by Anthony Jack find evidence for dual-process theory
- Law’s Michael Benza sounds off on duration of fraud case against Browns owner’s company
- School of Medicine’s Neil Korman discusses skin condition of Canadian former finance minister
- CWRU names Yale’s Amy Backus athletic director
- Political science’s Karen Beckwith is lead editor on new book series